Camouflaged Hybrid Cancer Cell‐Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple‐Negative Breast Cancer to Doxorubicin-Reference-Cited by-同舟云学术

Camouflaged Hybrid Cancer Cell‐Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple‐Negative Breast Cancer to Doxorubicin

Published:2021-07-17 Issue:41 Volume:31 Page:2103600
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Liu Yi¹²,Sukumar Uday K.¹,Kanada Masamitsu³,Krishnan Anandi⁴,Massoud Tarik F.¹,Paulmurugan Ramasamy¹⁵^ORCID

Affiliation:

1. Molecular Imaging Program at Stanford (MIPS) Stanford University School of Medicine Stanford CA 94305 USA

2. Department of Critical Care Medicine Chongqing Medical University Affiliated Second Hospital Chongqing 400016 China

3. Department of Pharmacology and Toxicology Institute for Quantitative Health Science and Engineering (IQ) Michigan State University East Lansing MI 48824 USA

4. Department of Pathology Stanford University School of Medicine Stanford CA 94305 USA

5. Canary Center for Cancer Early Detection Stanford University School of Medicine Stanford CA 94305 USA

Funder

Focused Ultrasound Foundation

National Institutes of Health

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adfm.202103600